Use access key #2 to skip to page content.
$2.40 -0.31 (-11.44%)
11/21/2008 4:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating:
*****

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating EXEL

Add Stock to Watchlist

What the Community Thinks

Total Members

2175 Outperforms
78 Underperforms
 

All-Stars

330 Outperforms
28 Underperforms
 

Wall Street

4 Outperforms
0 Underperforms
 

Members bullish on EXEL are also bullish on:

Members bearish on EXEL are also bearish on:

Ticker Tags

Micro Cap (5043), Research Services (8), Optionable (26), Life Sciences Tools and Services (59)
Suggest a tag

Exelixis, Inc. At A Glance

Current Price: $2.40
Last Trade Time: 11/21/2008 4:00 PM
Open: $2.76
Previous Close: $2.71
Daily Range: $2.11 - $2.92
52-Week Range: $2.59 - $9.98
Volume: 2,313,732
Market Cap: $286.18M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

EXEL VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for EXEL

More Headlines...

Top Bull Pitch

Recs

23

Exelixis, Inc. (EXEL)

Avatar ResearchLover (< 20) Submitted: 3/12/08 12:11 PM

I am a molecular biologist and have been at presentations for mid/late stage compounds, such as PPAR ligands, that EXEL is developing. They have the expertise to develop successful compounds. And they are at a bargain basement price now. If you need a signal to enter, wait for insider buying, whi...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Exelixis, Inc. (EXEL)

Avatar BRADYstocks (21.15) Submitted: 2/25/08 9:26 PM

This sector is a scary one! Fear, though, is a fools game. I don't expect this stock to move upwards in the very near future. The cash burn is, well, similar to that Texas A&M bonfire tradition.

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 358 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (EXEL)

Avatar metzinvest (34.06) Submitted: 11/17/08 2:48 PM : Outperform Start Price: $3.02 EXEL Score: -7.61

Insider buying is generally a good sign. Give it a little time and see what it does.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (EXEL)

Avatar expatriot08 (56.62) Submitted: 11/16/08 5:57 PM : Outperform Start Price: $3.01 EXEL Score: -8.17

Trusting that the recent insider buying is a good sign

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (EXEL)

Avatar BeerFund (64.08) Submitted: 11/14/08 2:52 PM : Outperform Start Price: $3.19 EXEL Score: -7.79

Already long, entering CAPS at lower price and adding to my position.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (EXEL)

Avatar WarEagle1988 (< 20) Submitted: 11/10/08 3:25 PM : Outperform Start Price: $3.48 EXEL Score: -13.98

Spec play. Good drug pipeline. Potential takeover target.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (EXEL)

Avatar hsmith1415 (34.44) Submitted: 11/08/08 10:07 AM : Outperform Start Price: $3.57 EXEL Score: -12.46

Got this idea from the TMF Silicon Valley tour...

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 358 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 4 of 4  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackMerrimanCo < 20 10/16/08 Outperform NS $4.15-42.17%-17.16%-25.01
TrackSoros < 20 03/31/08 Outperform NS $6.95-65.47%-42.54%-22.93 Toggle the visibility of 60-Second Pitch and replies
TrackEveillard 85.91 12/31/07 Outperform NS $8.63-72.19%-48.13%-24.06 Toggle the visibility of 60-Second Pitch and replies
TrackLazardCapit < 20 09/14/07 Outperform NS $10.44-77.01%-48.90%-28.12

Results 1 - 4 of 4  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links